Study of the Effect of Elastic Compression (French Class III) on Water Balance Change in Healthy Subjects
Study of the Effect of Class III Elastic Venous Compression Focused on 33 mmHg on Water Balance Change in Healthy Subjects. Exploratory, Randomized, Open-label, Controlled and Crossover Study
1 other identifier
interventional
23
1 country
1
Brief Summary
The main objective of this study is to compare precisely, under standardized test conditions, water balance changes in healthy subjects with or without the daytime use of compression stocking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2016
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedFirst Posted
Study publicly available on registry
July 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedAugust 24, 2016
August 1, 2016
1 month
June 30, 2016
August 23, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Evolution of the total bodily fluid volume in the daytime sequence measured by impedancemetry with or without daytime use of compression stocking
adjusted over 3 consecutive days
Secondary Outcomes (8)
Evolution of the water balance in daytime sequence,in night sequence and on a 24h sequence with or without daytime use of compression stocking
adjusted over 3 consecutive days
Evolution of the subject's weight (in kilograms), in daytime sequence, in night sequence and on a 24 h sequence with or without daytime use of compression stocking
adjusted over 3 consecutive days
Evolution of the volume of urine determined by weight (in kilograms),in daytime sequence, in night sequence and a 24h sequence with or without daytime use of compression stocking
adjusted over 3 consecutive days
Evolution days of the neck circumference (in centimeter) in a dynamic sequence, in supine sequence and on a 24h sequence with or without daytime use of compression stocking
adjusted over 3 consecutive days
Evolution of leg perimeters (in centimeter) in 3 points in dynamic sequence, in supine sequence , and over 24h sequence with or without daytime use of compression stocking
adjusted over 3 consecutive days
- +3 more secondary outcomes
Study Arms (2)
With use of compression stocking
EXPERIMENTALUse of compression stocking during 3 consecutives days
Without use of compression stocking
OTHERNo use of compression stocking during 3 consecutives days
Interventions
A class III (20 to 36 mm Hg) elastic compression stocking according to the french classification
No use of compression stocking
Eligibility Criteria
You may qualify if:
- Male subject aged 40 years old or more,
- Subject with a Body Mass Index (BMI) between 18.5 and 30 kg/m²,
- Subject with a body fat percentage between 11 and 27 % of his weight, as measured by impedancemetry,
- Subject with a muscle mass index of less than 55% of his weight, as measured by impedancemetry,
- Subject with a water status, as measured by impedancemetry, between + / - 5 liters of his normal value, as indicated by the impedancemetry,
- Healthy subject, registered in the French biomedical research volunteer national database,
- Subject whose lower limb measurements correspond to the size grid of the compression stocking used,
- Subject agreeing to abstain from alcohol intake during all hospitalization periods,
- Subject practicing under 5 hours of intense physical activity per week, on average, in the 4 weeks preceding the screening visit (marathon training, military training ...),
- Subject agreeing to abstain from any strenuous activity , especially sports, from the screening visit to the end of study (including during the out-patient period),
- Subject accepting the constraints of the study,
- Subject being available during the whole period of the study,
- Subject who has signed the consent form after being adequately informed and receiving the information sheet,
- Subject affiliated to the French social security system or receiving benefits of that type.
You may not qualify if:
- Subject who is a smoker or a former smoker who stopped smoking less than 6 months ago,
- Subject following a salt-free diet,
- Subject following or planning to follow a diet,
- Subject having a temperature ≥ 38,5°C in the morning,
- Subject having, upon clinical examination, a systolic blood pressure (SBP) \< 91 mmHg or \> 139 mmHg, a diastolic blood pressure (DBP) \< 41 mmHg or \> 89 mmHg, or a heart rate (HR) \< 40 bpm or \> 100 bpm, and judged clinically significant by the investigator,
- Subject having an intestinal transit disorder that disrupts hydroelectric balance,
- Alcohol-dependent subject or subject with a positive alcohol breath test,
- Subject suffering from insulin-dependent or uncontrolled diabetes (controlled diabetes is accepted),
- Subject with a serious, stabilized, or progressive illness (as judged by the investigator),
- Subject with hypertension or heart failure,
- Subject with known renal function disorders,
- Subject with known liver failure,
- Subject with venous insufficiency of clinical class C3, C4, C5 or C6 according to the Clinical / Etiological / Anatomical / Pathophysiological (CEAP) classification,
- Subject following long-term therapy with diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, nutritional supplements or opiates,
- Subject having, upon questioning or clinical examination, advanced peripheral neuropathy, skin infections, eczematous dermatitis, or weeping skin disorder of the leg,
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laboratoires Innotheralead
- Biotrialcollaborator
Study Sites (1)
Biotrial
Rennes, 35042, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hakim Charfi, MD
Biotrial
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2016
First Posted
July 7, 2016
Study Start
July 1, 2016
Primary Completion
August 1, 2016
Study Completion
August 1, 2016
Last Updated
August 24, 2016
Record last verified: 2016-08